Case Report: Catheter-associated multidrug-resistant Leclercia adecarboxylata bloodstream infection in a colon tumor patient - Scorecard - MDSpire

Case Report: Catheter-associated multidrug-resistant Leclercia adecarboxylata bloodstream infection in a colon tumor patient

  • By

  • Ning Du

  • Dan You

  • Zhe Chen

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Bloodstream Infection from Multidrug-Resistant Leclercia adecarboxylata Associated with Catheter Use in a Patient with Colon Cancer

At a Glance

CategoryDetail
ConditionCatheter-associated bloodstream infection caused by multidrug-resistant Leclercia adecarboxylata
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • Patient developed high fever and chills post-surgery, indicating severe infection.
  • Treatment was switched to meropenem after 4 days of ineffective cefoperazone-sulbactam, leading to clinical improvement.

Guideline-Based Recommendations

Diagnosis

    Management

    • Empirical treatment should be guided by antimicrobial sensitivity tests, specifically for multidrug-resistant strains.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        71-year-old male with colon cancer and catheter use.

        Meropenem was effective after initial treatment failure with cefoperazone-sulbactam.

        Clinical Best Practices

        • Conduct antimicrobial susceptibility testing for effective treatment.
        • Consider catheter removal in cases of catheter-associated infections to reduce infection risk.

        Related Resources & Content

        Original Source(s)

        Related Content